Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
J Allergy Clin Immunol Pract. 2020 Oct;8(9):2851-2857. doi: 10.1016/j.jaip.2020.07.020. Epub 2020 Jul 25.
The SARS-CoV2 pandemic has prompted a re-evaluation of our current practice of medicine. The seemingly abrupt worldwide spread of this disease resulted in immediate changes and a reduction in many allergy-focussed services and procedures. The reality of the long-term circulation of this virus in our communities requires us to evolve as a specialty. In this article, we outline current and future challenges in the management of food allergy in light of coronavirus disease 2019 (COVID-19). We focus on infant food allergy prevention, management of anaphylaxis, accurate diagnosis with oral food challenges, and active management of food allergy with oral immunotherapy. This article identifies the challenges of conflicting guidelines, shortcomings of acute management approaches, and inherent system deficiencies. We offer perspectives and strategies that can be implemented now, including an evaluation of virtual care and telemedicine for the management of food allergy. The use of a shared decision-making model results in novel approaches that can benefit our patients and our specialty for years to come. COVID-19 has forced us to re-evaluate our current way of thinking about food allergy management to better treat our patients.
SARS-CoV2 大流行促使我们重新评估当前的医学实践。这种疾病似乎在全球范围内突然传播,导致许多专注于过敏的服务和程序立即发生变化和减少。这种病毒在我们社区中长期传播的现实要求我们作为一个专业不断发展。在本文中,我们根据 2019 年冠状病毒病 (COVID-19) 概述了食物过敏管理方面的当前和未来挑战。我们重点介绍了婴儿食物过敏预防、过敏反应管理、口服食物挑战的准确诊断以及口服免疫疗法的积极管理。本文确定了冲突指南、急性管理方法的缺点和固有系统缺陷的挑战。我们提供了可以立即实施的观点和策略,包括对管理食物过敏的虚拟护理和远程医疗进行评估。使用共享决策模型可以带来新的方法,使我们的患者和我们的专业受益。COVID-19 迫使我们重新评估我们目前对食物过敏管理的思维方式,以更好地治疗我们的患者。